Hemant K. Bid

3.1k total citations
72 papers, 2.5k citations indexed

About

Hemant K. Bid is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hemant K. Bid has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Oncology and 15 papers in Immunology. Recurrent topics in Hemant K. Bid's work include Cytokine Signaling Pathways and Interactions (10 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Hemant K. Bid is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Hemant K. Bid collaborates with scholars based in India, United States and Japan. Hemant K. Bid's co-authors include Rituraj Konwar, Peter J. Houghton, Rama Devi Mittal, Parmeet K. Manchanda, Ryan D. Roberts, Kashif Hanif, Bandana Chakravarti, Monisha Banerjee, Doris A. Phelps and Naibedya Chattopadhyay and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Hemant K. Bid

72 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hemant K. Bid India 33 1.2k 574 422 383 318 72 2.5k
Yingqi Zhang China 28 1.3k 1.1× 471 0.8× 482 1.1× 241 0.6× 425 1.3× 127 2.8k
Stavroula Baritaki Greece 31 1.5k 1.3× 715 1.2× 571 1.4× 240 0.6× 492 1.5× 96 2.6k
Bal L. Lokeshwar United States 33 1.5k 1.2× 935 1.6× 592 1.4× 522 1.4× 461 1.4× 74 3.4k
Vijay Pandey China 30 1.4k 1.2× 658 1.1× 706 1.7× 226 0.6× 281 0.9× 105 2.5k
Patrick M. Navolanic United States 19 2.3k 1.9× 1.0k 1.8× 562 1.3× 371 1.0× 324 1.0× 23 3.5k
Ana Bela Sarmento‐Ribeiro Portugal 30 1.5k 1.3× 729 1.3× 743 1.8× 351 0.9× 302 0.9× 130 3.2k
Qing Xu China 28 1.3k 1.1× 415 0.7× 714 1.7× 286 0.7× 244 0.8× 102 2.7k
Kenneth W. Yip Canada 23 1.5k 1.3× 522 0.9× 697 1.7× 290 0.8× 251 0.8× 40 2.7k
Si Sun China 28 1.4k 1.2× 857 1.5× 737 1.7× 565 1.5× 319 1.0× 147 2.9k
Ana Preto Portugal 34 1.8k 1.5× 1.2k 2.1× 560 1.3× 272 0.7× 218 0.7× 74 3.7k

Countries citing papers authored by Hemant K. Bid

Since Specialization
Citations

This map shows the geographic impact of Hemant K. Bid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemant K. Bid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemant K. Bid more than expected).

Fields of papers citing papers by Hemant K. Bid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemant K. Bid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemant K. Bid. The network helps show where Hemant K. Bid may publish in the future.

Co-authorship network of co-authors of Hemant K. Bid

This figure shows the co-authorship network connecting the top 25 collaborators of Hemant K. Bid. A scholar is included among the top collaborators of Hemant K. Bid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemant K. Bid. Hemant K. Bid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shackleford, Terry J., Angelina V. Vaseva, Hemant K. Bid, et al.. (2023). Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma. Molecular Cancer Therapeutics. 22(4). 539–550. 5 indexed citations
2.
Bid, Hemant K., Doris A. Phelps, Denis C. Guttridge, et al.. (2016). The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma. Molecular Cancer Therapeutics. 15(5). 1018–1028. 66 indexed citations
3.
Lopez, Gonzalo, Chad J. Creighton, Hemant K. Bid, et al.. (2015). HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components. Molecular Cancer Research. 14(1). 35–43. 17 indexed citations
4.
Bill, Kate Lynn J., Jeannine Garnett, Isabelle Meaux, et al.. (2015). SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma. Clinical Cancer Research. 22(5). 1150–1160. 86 indexed citations
5.
Rath, Kellie S., Shan K. Naidu, Hemant K. Bid, et al.. (2014). HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer. Cancer Research. 74(8). 2316–2327. 76 indexed citations
6.
Bid, Hemant K., Doris A. Phelps, Linlin Xiao, et al.. (2013). Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. Clinical Cancer Research. 19(24). 6716–6729. 49 indexed citations
7.
Bid, Hemant K., Ryan D. Roberts, Maren Cam, et al.. (2013). ΔNp63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis. Cancer Research. 74(1). 320–329. 47 indexed citations
8.
Bid, Hemant K., Cheryl A. London, Haihong Zhong, et al.. (2013). Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy. Clinical Cancer Research. 19(11). 2984–2994. 18 indexed citations
9.
Wang, Bo, Shu‐Hao Hsu, Xinmei Wang, et al.. (2013). Reciprocal Regulation of MicroRNA-122 and c-Myc in Hepatocellular Cancer: Role of E2F1 and Transcription Factor Dimerization Partner 2. Hepatology. 59(2). 555–566. 97 indexed citations
10.
Sugahara, Kazuyuki, Kuntebommanahalli N. Thimmaiah, Hemant K. Bid, Peter J. Houghton, & Kanchugarakoppal S. Rangappa. (2012). Correction: Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule. PLoS ONE. 7(10). 12 indexed citations
11.
Chakravarti, Bandana, Ranjani Maurya, Jawed A. Siddiqui, et al.. (2012). In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: Role of pro-apoptotic effects of oleanolic acid and urosolic acid. Journal of Ethnopharmacology. 142(1). 72–79. 131 indexed citations
12.
Bid, Hemant K., Jun Zhan, Doris A. Phelps, Raushan T. Kurmasheva, & Peter J. Houghton. (2011). Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 Is Reversed by IGF-2. Molecular Cancer Therapeutics. 11(3). 649–659. 57 indexed citations
13.
Bid, Hemant K., et al.. (2011). Preliminary studies on CD36 gene in type 2 diabetic patients from north India.. PubMed. 134. 107–12. 18 indexed citations
14.
Yadav, Awesh K., Abhinav Agarwal, Sanyog Jain, et al.. (2010). Chondroitin Sulphate Decorated Nanoparticulate Carriers of 5-Fluorouracil: Development and <I>In Vitro</I> Characterization. Journal of Biomedical Nanotechnology. 6(4). 340–350. 14 indexed citations
15.
Saxena, Madhukar, et al.. (2009). Overt diabetic complications in obese Type 2 diabetes mellitus patients from North India.. Archives of applied science research. 1(2). 57–66. 6 indexed citations
16.
Reddy, K. Papi, Hemant K. Bid, Veena Nayak, et al.. (2009). In vitro and in vivo anticancer activity of 2-deacetoxytaxinine J and synthesis of novel taxoids and their in vitro anticancer activity☆. European Journal of Medicinal Chemistry. 44(10). 3947–3953. 21 indexed citations
17.
Samanta, Krishnananda, Bandana Chakravarti, Jitendra K. Mishra, et al.. (2009). Anti-tumor activity of a new series of benzoxazepine derivatives in breast cancer. Bioorganic & Medicinal Chemistry Letters. 20(1). 283–287. 47 indexed citations
18.
Konwar, Rituraj, Naibedya Chattopadhyay, & Hemant K. Bid. (2008). Genetic polymorphism and pathogenesis of benign prostatic hyperplasia. British Journal of Urology. 102(5). 536–544. 29 indexed citations
19.
Manchanda, Parmeet K., Hemant K. Bid, Anant Kumar, & Rama Devi Mittal. (2006). Genetic association of interleukin-1β and receptor antagonist (IL-1Ra) gene polymorphism with allograft function in renal transplant patients. Transplant Immunology. 15(4). 289–296. 20 indexed citations
20.
Bid, Hemant K. & Rama Devi Mittal. (2005). Internet Resources and Urology. Urologia Internationalis. 74(1). 1–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingqi Zhang Breakdown of academic impact, for papers by Stavroula Baritaki Breakdown of academic impact, for papers by Bal L. Lokeshwar Breakdown of academic impact, for papers by Vijay Pandey Breakdown of academic impact, for papers by Patrick M. Navolanic Breakdown of academic impact, for papers by Ana Bela Sarmento‐Ribeiro Breakdown of academic impact, for papers by Qing Xu Breakdown of academic impact, for papers by Kenneth W. Yip Breakdown of academic impact, for papers by Si Sun Breakdown of academic impact, for papers by Ana Preto
Rankless by CCL
2026